This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hospira's TheraDoc™ Clinical Surveillance System To Support Infection Prevention And Patient Safety Efforts At CHRISTUS Health

LAKE FOREST, Ill., March 9, 2012 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that CHRISTUS Health, one of the country's 10 largest Catholic healthcare systems, has selected Hospira's TheraDoc™ clinical surveillance system to support its patient safety and infection prevention efforts across 23 hospitals in Arkansas, Louisiana and Texas.

CHRISTUS hospitals will use the Clinical Intelligence™ Platform -- which is the engine that powers the TheraDoc system -- to collect relevant patient data from multiple hospital information sources including laboratory, pharmacy, radiology and surgery, helping clinicians identify changes in patients' conditions and alerting them to potential problems that need to be addressed. The Infection Control Assistant™ module will provide automated surveillance and tracking of healthcare-associated infections (HAIs) -- a critical healthcare issue that impacts more than 1.7 million patients -- an estimated 60 percent of which are caused by a drug-resistant bacteria, in the United States each year.(1,2) The TheraDoc system also will be used to facilitate mandatory reporting requirements such as HAI reporting, as well as a range of other patient safety and quality improvement activities.

According to Brandee Lujan, R.N., infection preventionist at CHRISTUS Health and member of the surveillance software review committee, the TheraDoc system was selected after a rigorous, year-long evaluation process that included several potential vendors. Lujan said CHRISTUS Health needed a solution that could assist in more quickly capturing patient safety trends and allow clinicians to proactively respond in order to support its "culture of safety" -- a philosophy aimed at taking the already high-quality care provided by CHRISTUS Health to even higher levels. A further challenge was identifying a system that could support and improve coordination between hospital departments such as infection prevention and pharmacy, as well as a large number of different facilities across many regions.

"We were most impressed with the TheraDoc team -- when we asked questions, their responses made it clear that they were proactive and planned ahead," Lujan said. "They have worked closely with the National Healthcare Safety Network (NHSN) and other agencies to understand what's coming down the road. When we asked how they were going to address future challenges, their answers were solid, and we could tell that they understood our needs and were capable of meeting them -- now and into the future. This proactive approach is exactly what we need in a clinical information technology partner."

France Pitera, vice president, Clinical Information Technology, Hospira, said the adoption of TheraDoc technology by CHRISTUS Health reflects the critical need for a comprehensive clinical surveillance platform that can help address the fragmentation of medical information in hospitals and the explosion of information fueled by electronic medical record systems.

"Collecting more patient data is only part of the equation," Pitera said. "Intelligent clinical surveillance systems must transform that information into pertinent, organized clinical knowledge, and deliver it to the right clinicians at the right time. This enables clinicians to take action to improve patient safety and reduce the added costs of treating HAIs and other preventable injuries. We are impressed with CHRISTUS Health's culture of safety and honored to partner with the organization to further its patient safety and quality initiatives."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs